Stay updated on Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Sign up to get notified when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.

Latest updates to the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a Terminated status with a note that the decision was for business reasons and not related to safety concerns, and this termination detail is reflected in the Study Details section.SummaryDifference0.1%

- Check10 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.2%

- Check18 days agoChange DetectedScreenshots depict the same study details page with no substantive content changes; any observed diffs appear cosmetic.SummaryDifference0.1%

- Check25 days agoChange DetectedTwo screenshots show only layout/navigation adjustments on the page. There are no changes to the study design, eligibility criteria, outcomes, enrollment, or current status.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.4.2 was applied. The study page content remains unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1; there are no visible changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.